patent for semaglutide As the semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic Novo Nordisk patent expiry opens

Create an Account 8 in stock Chat With Holio Care Shop by goal

Do not stop or alter your treatment without medical advice, even if your routine changes

As a result, adverse side effects such as nausea, headache, increased heart rate (a.k.a tachycardia), and skin irritation near the application site are possible, says Dr

Oral weight loss pills like Wegovy work through the same GLP-1 mechanism, so weight loss pills' side effects are similar to the injection, primarily mild nausea and constipation

Expanding semaglutide access across multiple geographies is a big win for patients and the industry Great Statergy using Ajantas reach in market with the Biocons vast experience in Peptides See more comments To view or add a comment, sign in More Relevant Posts This partnership indeed reflects a smart India-led globalisation model